All In Biotech

Free tool

FAERS Monitor: Katerzia

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 211340 or its brand name (Katerzia, Amlodipine Benzoate). Reports on generic versions are filed under their own applications.

Reports

272,620

Serious

210,866

77% of reports

Hospitalization

109,379

Death reported

29,868

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue16,575
  • diarrhoea14,880
  • nausea14,108
  • dyspnoea13,790
  • drug ineffective12,841
  • off label use12,062
  • dizziness11,278
  • headache10,422
  • acute kidney injury9,953
  • pain9,610
  • vomiting9,272
  • fall8,925
  • asthenia8,849
  • hypotension8,776
  • malaise8,330

Reports by year received

View as table
YearReports
2004744
2005878
20061,036
20071,407
20081,912
20093,213
20104,129
20115,415
20127,098
20137,601
201410,322
201514,615
201616,314
201718,466
201822,937
201924,686
202023,029
202120,669
202218,630
202319,083
202417,923
202518,338
202614,174

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,781,539 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal9,9535.35.232,673
hypotensionSignal8,7763.53.415,003
fallSignal8,9252.12.15,073
dyspnoea13,7901.91.95,907
asthenia8,8491.81.83,344
diarrhoea14,8801.81.85,299
dizziness11,2781.81.73,718
fatigue16,5751.71.64,382
vomiting9,2721.51.51,717
malaise8,3301.51.41,273
nausea14,1081.41.41,520
headache10,4221.31.3677
pain9,6101.21.2356
off label use12,0621.11.047
drug ineffective12,8410.70.71,138

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.